Back to search
Erythropoietic Protoporphyria (EPP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Erythropoietic Protoporphyria (EPP) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Erythropoietic Protoporphyria (EPP) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pr…
The purpose of this study is to collect information about the effects of EPP/XLP in adults and adolescents. This is an observational study in which participants…
To evaluate the long-term safety and tolerability of oral dersimelagon.
Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) result from genetic defects of heme biosynthesis that cause life-long, painful cutaneous s…
This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.